| Page 137 | Rogel Cancer Center | University of Michigan

Patient and Visitor Guide Thank you for choosing the University of Michigan Rogel Cancer Center. Whether you are coming to the cancer center for your first appointment, are newly diagnosed or are undergoing treatment, we have designed the cancer center with you -- the patient -- in mind. We know that what you're going through is not easy. You have a lot of questions, and we're here to answer them. Read more about Patient and Visitor Guide	Less financial burden for cancer patients with paid sick leave, study finds Researchers found that only 55 percent of colorectal cancer patients who were employed at the time of diagnosis retained their jobs after treatment. Patients who had paid sick leave were nearly twice as likely to retain their jobs as those without paid sick leave. Read more about Less financial burden for cancer patients with paid sick leave, study finds	Researchers take first step in precision medicine for penile cancer Researchers have identified potential genetic alterations in penile cancer that could pave the way for targeted treatments. The new study describes a complex landscape that could suggest potential clinical trials of targeted therapies – and potential limitations in some patients. Read more about Researchers take first step in precision medicine for penile cancer	Why does tamoxifen work better in some women? New studies add to questions about predicting whether tamoxifen will be effective in an individual breast cancer patient. Read more about Why does tamoxifen work better in some women?
Researchers use ovarian follicles to preserve fertility Researchers at the University of Michigan have identified a potential new approach to fertility preservation for young cancer patients that addresses concerns about beginning cancer treatment immediately and the possibility of reintroducing cancer cells during the fertility preservation process. Read more about Researchers use ovarian follicles to preserve fertility	U-M Rogel Cancer Center names Bhramar Mukherjee to lead cancer prevention, control research The University of Michigan Rogel Cancer Center has appointed Bhramar Mukherjee, Ph.D., as associate director for population science research. Read more about U-M Rogel Cancer Center names Bhramar Mukherjee to lead cancer prevention, control research	Genetic mutations differ within a single tumor, study finds When researchers looked at different areas within an individual rectal cancer sample, they found cases in which each area contained different genetic mutations. The findings could have significant implications for treatment recommendations. Read more about Genetic mutations differ within a single tumor, study finds	Study offers insights to how ovarian cancer grows – and potential to stop it Can any cancer cell form another tumor, or is it only select cancer stem cells that give rise to new cancer cells? The answer, a new study finds, is both. Read more about Study offers insights to how ovarian cancer grows – and potential to stop it
Global task force tackles problem of untreatable cancers and disease relapse Combinations of a significant number of non-toxic chemicals, many of which can be found in plants and foods, may offer a chance to stop untreatable cancers and prevent disease relapse. Read more about Global task force tackles problem of untreatable cancers and disease relapse	Preclinical Molecular Imaging State-of-the-Art Center for Molecular Imaging As part of Shared Resources at the University of Michigan Rogel Cancer Center, the Preclinical Molecular Imaging (PMI) Shared Resource uses the latest imaging instruments, in a state-of-the-art facility, for expert computational analysis. Our imaging services include: Magnetic Resonance Imaging (MRI) Magnetic Resonance Spectroscopy (MRS) Computed Tomography (CT) Positron Emission Tomography (PET) Bioluminescence Imaging Fluorescence Imaging Read more about Preclinical Molecular Imaging

State-of-the-Art Center for Molecular Imaging

Pages